Lipophilicity and Transporter Influence on Blood-Retinal Barrier Permeability: A Comparison with Blood-Brain Barrier Permeability

[31] Makihara A(1990)Selective properties of the vitreous barrier J Biol Chem 265 18035-18040

[32] Tsujikawa Y(2005)Sucrose permeability of the blood-retinal and blood-brain barriers. Effects of diabetes, hypertonicity, and iodate Drug Metab Dispos 33 1547-1554

[33] Yoneyama D(1997)Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and Clin Electroencephalogr 28 143-147

[34] Mori S(1986) hybridization Neurology 36 1119-1121

[35] Terasaki T(2000)The blood-brain barrier sodium-dependent multivitamin transporter: a molecular functional Brain Res 879 115-121

[36] Akanuma S(1997)- Exp Eye Res 65 771-779

[37] Tomi M(2004) correlation J Neurochem 90 272-286

[38] Tachikawa M(2002)Visual electrophysiology in Parkinson’s disease: PERG, VEP and visual P300 Curr Opin Neurobiol 12 49-56

[39] Tagami M(2003)Effect of L-dopa on visual evoked potential in patients with Parkinson’s disease J Biol Chem 278 43489-43495

[40] Kusuhara S(2007)The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier Brain Res 1181 44-50

[31] Makihara A(1990)Selective properties of the vitreous barrier J Biol Chem 265 18035-18040

[32] Tsujikawa Y(2005)Sucrose permeability of the blood-retinal and blood-brain barriers. Effects of diabetes, hypertonicity, and iodate Drug Metab Dispos 33 1547-1554

[33] Yoneyama D(1997)Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and Clin Electroencephalogr 28 143-147

[34] Mori S(1986) hybridization Neurology 36 1119-1121

[35] Terasaki T(2000)The blood-brain barrier sodium-dependent multivitamin transporter: a molecular functional Brain Res 879 115-121

[36] Akanuma S(1997)- Exp Eye Res 65 771-779

[37] Tomi M(2004) correlation J Neurochem 90 272-286

[38] Tachikawa M(2002)Visual electrophysiology in Parkinson’s disease: PERG, VEP and visual P300 Curr Opin Neurobiol 12 49-56

[39] Tagami M(2003)Effect of L-dopa on visual evoked potential in patients with Parkinson’s disease J Biol Chem 278 43489-43495

[40] Kusuhara S(2007)The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier Brain Res 1181 44-50